This week, the FDA will release its verdict on Biogen and Ionis’ ALS candidate tofersen and three other investigational medicines for psychiatric disorders, hormonal insufficiency and gut infection.
FDA Action Alert: Biogen/Ionis, Seres, Otsuka/Lundbeck and More Read More »
Los pacientes ingresados en unidades de cuidados intensivos a menudo reciben transfusiones de sangre, pero cada vez hay más pruebas de posibles daños así como de beneficios.
Glóbulos rojos, plasma y plaquetas | Transfusión en pacientes críticos Read More »
Revisión sobre patogénesis, epidemiología, clínica y vacunación de dengue.
Revisión sobre patogénesis, epidemiología y clínica | Dengue Read More »
The acquisition, which would be Boston Scientific’s largest in recent history, would add to the company’s cardiac portfolio.
Boston Scientific considering purchase of Shockwave Medical: Bloomberg Read More »
Generative AI has roared onto the tech scene through the large language model backing ChatGPT. Companies are already deploying the algorithms in hospitals. Should healthcare be taking a pause?
Cancer vaccines enjoyed a moment in the spotlight at AACR as Moderna, Merck, Nykode Therapeutics and Transgene shared promising updates.
Cancer Vaccines Steal the Stage at AACR: Nykode, Transgene, Moderna and Merck Read More »
The spine surgery specialist expects the robotic platform to begin generating revenue in 2025.
Alphatec buys robotic spine navigation system for $55M Read More »
A patient who had DePuy’s Attune knee system implanted, and then replaced when it loosened, claims the company downplayed the risks of the device.
Lawsuit accuses J&J subsidiary of selling faulty knee replacements Read More »
AbbVie shared more positive results for its migraine prevention drug, Qulipta, just three days after FDA approval to expand its label.
AbbVie’s Migraine Drug Scores Another Phase III Win Read More »
Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.
Friday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market Read More »
